Literature DB >> 10446864

Increased number of interleukin-10-producing cells in systemic lupus erythematosus patients and their first-degree relatives and spouses in Icelandic multicase families.

G Gröndal1, H Kristjansdottir, B Gunnlaugsdottir, A Arnason, I Lundberg, L Klareskog, K Steinsson.   

Abstract

OBJECTIVE: To evaluate the production of interleukin-10 (IL-10) as well as levels of IgG and antinuclear antibodies (ANA) in systemic lupus erythematosus (SLE) patients and their first-degree relatives and spouses in Icelandic SLE multicase families.
METHODS: IL-10 production was studied by enzyme-linked immunospot assay of freshly isolated peripheral blood mononuclear cells. Total IgG and ANA were also investigated. Subjects consisted of 23 SLE patients and 47 of their first-degree relatives in 9 Icelandic multicase families. Subjects were ethnically matched by a group of healthy controls. A separate study investigated 12 SLE patients (also from SLE multicase families) and their spouses and a matched group of healthy controls. A predefined protocol was used to obtain both clinical and laboratory data, including information about SLE and other autoimmune disorders.
RESULTS: The SLE patients had a significantly higher number of IL-10-producing cells compared with both first-degree relatives and healthy controls (P = 0.0005 and P < 0.0001, respectively). First-degree relatives also had a significantly higher number of IL-10-producing cells compared with healthy controls (P = 0.01). This was also true for the spouses of SLE patients, who had a higher number of IL-10-producing cells compared with matched healthy controls (P = 0.02).
CONCLUSION: SLE patients and their first-degree relatives, as well as a limited number of healthy spouses of SLE patients, had increased numbers of spontaneous IL-10-producing cells. These data support the hypothesis that IL-10 production may be genetically determined, and may predispose one toward development of SLE. This has previously been suggested by studies of SLE patients and their relatives in another ethnic population, using another method for measuring IL-10 production. Although these data are based on a small number of observations, they suggest that not only genetic but also environmental factors may be of importance in determining IL-10 production, since the spouses of SLE patients also had an increased number of IL-10-producing cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10446864     DOI: 10.1002/1529-0131(199908)42:8<1649::AID-ANR13>3.0.CO;2-D

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  The effect of interleukin-10 and of interleukin-12 on the in vitro production of anti-double-stranded DNA antibodies from patients with systemic lupus erythematosus.

Authors:  J Tyrrell-Price; P M Lydyard; D A Isenberg
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Interleukin-10 receptor expression and signalling were down-regulated in CD4⁺ T cells of lupus nephritis patients.

Authors:  H D Cui; Z M Qi; L L Yang; L Qi; N Zhang; X L Zhang; S Y Du; Y Jiang
Journal:  Clin Exp Immunol       Date:  2011-06-02       Impact factor: 4.330

3.  Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE.

Authors:  J Rönnelid; A Tejde; L Mathsson; K Nilsson-Ekdahl; B Nilsson
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

4.  Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus.

Authors:  Claudia Azucena Palafox-Sánchez; Edith Oregon-Romero; Diana Celeste Salazar-Camarena; Yeminia Maribel Valle; Jesús René Machado-Contreras; Alvaro Cruz; Mariana Orozco-López; Gerardo Orozco-Barocio; Mónica Vázquez-Del Mercado; José Francisco Muñoz-Valle
Journal:  Clin Exp Med       Date:  2014-09-25       Impact factor: 3.984

5.  Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy.

Authors:  Nailú Angélica Sinicato; Mariana Postal; Simone Appenzeller; Timothy B Niewold
Journal:  Pharmaceut Med       Date:  2017-01-25

Review 6.  Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.

Authors:  Christian Fercher; Sahar Keshvari; Michael A McGuckin; Ross T Barnard
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-19

7.  Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.

Authors:  Weijia Yuan; Stephen J DiMartino; Patricia B Redecha; Lionel B Ivashkiv; Jane E Salmon
Journal:  Arthritis Rheum       Date:  2011-01

Review 8.  Advances in lupus genetics.

Authors:  Timothy B Niewold
Journal:  Curr Opin Rheumatol       Date:  2015-09       Impact factor: 5.006

9.  Cutting edge: IL-10-mediated tristetraprolin induction is part of a feedback loop that controls macrophage STAT3 activation and cytokine production.

Authors:  Anthony Gaba; Sergei I Grivennikov; Mahn Vu Do; Deborah J Stumpo; Perry J Blackshear; Michael Karin
Journal:  J Immunol       Date:  2012-08-03       Impact factor: 5.422

Review 10.  Regulatory T-cell-associated cytokines in systemic lupus erythematosus.

Authors:  Akiko Okamoto; Keishi Fujio; Tomohisa Okamura; Kazuhiko Yamamoto
Journal:  J Biomed Biotechnol       Date:  2011-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.